Most drug discovery efforts require commercial investment to reach the clinic and address unmet medical needs. On this front, SPARK has been quite successful.
Since 2006, forty-eight projects funded by SPARK have been licensed to either existing biopharmaceutical companies or to new startups.
We have been successful in numerous therapeutic areas including child and maternal health, oncology, and anti-infectives. Below is a word cloud generated from summaries of our graduated projects